May 15, 2023
Q2 2023
Summary / Key Findings:
  • Results were reported from 7 sites (including 2 new sites) across the United States
  • Geographical differences were observed for opioids, poly-drug use, NPS and xylazine
  • Fentanyl overwhelming remains the most commonly detected opioid nationally
  • Numerous NPS were detected, including metonitazene, N-desethyl isotonitazene, bromazolam, N,N-dimethylpentylone, and more
DOWNLOAD THE REPORT